loadpatents
Patent applications and USPTO patent grants for Pujala; Brahmam.The latest application filed is for "heterocyclic compounds as kinase inhibitors".
Patent | Date |
---|---|
Aryl Hydrocarbon Receptor Activators App 20220281824 - Kolluri; Siva Kumar ;   et al. | 2022-09-08 |
Heterocyclic Compounds As Kinase Inhibitors App 20220281859 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-09-08 |
Heterocyclic Compounds As Kinase Inhibitors App 20220273659 - PHAM; Son Minh ;   et al. | 2022-09-01 |
Heterocyclic Compounds And Uses Thereof App 20220220115 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-07-14 |
Heterocyclic Compounds And Uses Thereof App 20220169646 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-06-02 |
Heterocyclic Compounds And Uses Thereof App 20220168313 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-06-02 |
Heterocyclic Compounds And Uses Thereof App 20220162229 - CHAKRAVARTY; Sarvajit ;   et al. | 2022-05-26 |
Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors Grant 11,332,473 - Chakravarty , et al. May 17, 2 | 2022-05-17 |
Ectonucleotide Pyrophosphatase-phosphodiesterase-1 (enpp1) Inhibitors And Uses Thereof App 20220135598 - Pujala; Brahmam ;   et al. | 2022-05-05 |
Modulators of integrated stress response pathway Grant 11,318,133 - Delgado Oyarzo , et al. May 3, 2 | 2022-05-03 |
Heterocyclic compounds and uses thereof Grant 11,299,493 - Chakravarty , et al. April 12, 2 | 2022-04-12 |
Diarylhydantoin compounds and methods of use thereof Grant 11,292,782 - Chakravarty , et al. April 5, 2 | 2022-04-05 |
Inhibitors Of Integrated Stress Response Pathway App 20220071966 - DELGADO OYARZO; Luz Marina ;   et al. | 2022-03-10 |
Inhibitors of integrated stress response pathway Grant 11,230,542 - Bernales , et al. January 25, 2 | 2022-01-25 |
Inhibitors Of Arginase App 20220017541 - BELMAR; Sebastian ;   et al. | 2022-01-20 |
Compounds and Methods of Use App 20220000847 - Rai; Roopa ;   et al. | 2022-01-06 |
Heterocyclic compounds as kinase inhibitors Grant 11,174,252 - Pham , et al. November 16, 2 | 2021-11-16 |
Inhibitors of integrated stress response pathway Grant 11,166,942 - Delgado Oyarzo , et al. November 9, 2 | 2021-11-09 |
Atf6 Inhibitors And Uses Thereof App 20210221803 - ALFARO; Jennifer ;   et al. | 2021-07-22 |
Compounds and methods of use Grant 11,053,216 - Rai , et al. July 6, 2 | 2021-07-06 |
Pyrrole and pyrazole compounds and methods of use thereof Grant 11,034,669 - Chakravarty , et al. June 15, 2 | 2021-06-15 |
Modulators Of Integrated Stress Response Pathway App 20200390759 - DELGADO OYARZO; Luz Marina ;   et al. | 2020-12-17 |
ATF6 inhibitors and uses thereof Grant 10,829,485 - Alfaro , et al. November 10, 2 | 2020-11-10 |
Heterocyclic compounds and uses thereof Grant 10,807,994 - Chakravarty , et al. October 20, 2 | 2020-10-20 |
Heterocyclic Compounds And Uses Thereof App 20200325142 - CHAKRAVARTY; Sarvajit ;   et al. | 2020-10-15 |
Inhibitors Of Integrated Stress Response Pathway App 20200270232 - BERNALES; Sebastian ;   et al. | 2020-08-27 |
Heterocyclic Compounds And Methods Of Use App 20200247812 - Kind Code | 2020-08-06 |
Pyrrole And Pyrazole Compounds And Methods Of Use Thereof App 20200239433 - Chakravarty; Sarvajit ;   et al. | 2020-07-30 |
Inhibitors Of Fibroblast Activation Protein App 20200216417 - BERNALES; Sebastian ;   et al. | 2020-07-09 |
Inhibitors Of Fibroblast Activation Protein App 20200206216 - Pujala; Brahmam ;   et al. | 2020-07-02 |
Diarylhydantoin Compounds And Methods Of Use Thereof App 20200199098 - Chakravarty; Sarvajit ;   et al. | 2020-06-25 |
Dual Inhibitors Of Alk5 And P38a Map Kinase App 20200171030 - CHAKRAVARTY; Sarvajit ;   et al. | 2020-06-04 |
Inhibitors Of Integrated Stress Response Pathway App 20200101047 - DELGADO OYARZO; Luz Marina ;   et al. | 2020-04-02 |
Compounds and Methods of Use App 20200071296 - Rai; Roopa ;   et al. | 2020-03-05 |
Compounds and methods of use Grant 10,501,436 - Rai , et al. Dec | 2019-12-10 |
Atf6 Inhibitors And Uses Thereof App 20190367497 - ALFARO; Jennifer ;   et al. | 2019-12-05 |
Heterocyclic Compounds As Kinase Inhibitors App 20190248774 - PHAM; Son Minh ;   et al. | 2019-08-15 |
Inhibitors Of Fibroblast Activation Protein App 20190185451 - ALFARO; Jennifer ;   et al. | 2019-06-20 |
Inhibitors Of Integrated Stress Response Pathway App 20190177310 - BERNALES; Sebastian ;   et al. | 2019-06-13 |
Heterocyclic Compounds And Uses Thereof App 20190106436 - Chakravarty; Sarvajit ;   et al. | 2019-04-11 |
Heterocyclic Compounds And Uses Thereof App 20190106427 - Chakravarty; Sarvajit ;   et al. | 2019-04-11 |
Heterocyclic compounds and methods of use Grant 10,189,826 - Pujala , et al. Ja | 2019-01-29 |
Compounds and Methods of Use App 20180208577 - Rai; Roopa ;   et al. | 2018-07-26 |
Compounds and methods of use Grant 10,030,004 - Rai , et al. July 24, 2 | 2018-07-24 |
Heterocyclic Compounds and Methods of Use App 20180051013 - Pujala; Brahmam ;   et al. | 2018-02-22 |
Heterocyclic compounds and methods of use Grant 9,670,172 - Chakravarty , et al. June 6, 2 | 2017-06-06 |
Compounds and Methods of Use App 20160326137 - Rai; Roopa ;   et al. | 2016-11-10 |
Heterocyclic Compounds and Methods of Use App 20160272645 - RAI; Roopa ;   et al. | 2016-09-22 |
Heterocyclic Compounds And Methods Of Use App 20150065519 - Chakravarty; Sarvajit ;   et al. | 2015-03-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.